Use of Blood and Plasma in Norwegian Physician-staffed Helicopter Emergency Medical Systems

• Status: Unknown status
• Trial end date: 2018-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The main objective of this study is to evaluate the use of RBC, FDP, WB in the treatment of exsanguinating patients by physician-staffed emergency medical services in Norway, with focus on prehospital transfusion complications and safety.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Haukeland University Hospital
• Collaborators: Helse Forde; Helse Førde; Helse Stavanger HF; Oslo University Hospital; Sorlandet Hospital HF; St. Olavs Hospital; Sykehuset Innlandet HF; University Hospital of North Norway; Vestre Viken Hospital Trust

Criteria

Inclusion Criteria:

• All patients in haemorrhagic shock needing volume replacement and receiving prehospital transfusion of blood products according to listed indicators below:

• Patients with mechanism of injury compatible with severe haemorrhage and/or haemorrhagic shock (e.g. penetrating torso injury, visible massive bleeding)

• Radial pulse > 100 beats/min or absent/weak radial pulse

• Systolic blood pressure (SBP) < 90 mmHg

• Altered mental status (reduced GCS) in the absence of head injury or known intoxication

Exclusion Criteria:

• Patients with known previous serious allergic reactions to blood product transfusions

• Patients who refuse blood products on religious grounds, e.g. Jehovah´s Witness